Poland· PL-100512100

Ranolazine Aurovitas

A ranolazine product containing ranolazinum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC C01EB18

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ranolazinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ranolazine is registered in 16 of 19 countries.

Countries holding a registration under ATC C01EB18 (ranolazine), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search ranolazine products by name

Ranolazine · ATC C01EB18

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ranolazine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.49 in United States to $5.07 in Switzerland — a ×10 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Ranolazine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

CH Switzerland$5.07
ES Spain$1.58
IT Italy$0.87
US United States$0.49 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Ranolazinum
Manufacturer: Aurovitas Pharma Polska Sp. z o.o.
Country: Poland (PL)
ATC code: C01EB18
ATC class: Ranolazine
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 3

gtin
05909991608194
gtin
05909991608200
gtin
05909991608217

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

335 interactions on record for ranolazine.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ranolazine against other medicines How interaction checks work

Ranolazine · interactions on record

335 records

78 severe
205 moderate
29 minor
23 info

Most severe, free to view

ClotrimazoleA01AB18severe
PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ranolazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ranolazine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Austria · Rande, Ranogelan
Bulgaria · Равена
Cyprus · Ranolazine Accord, Ranolazine Remedica
Czechia · Ranolazine Umedica
Germany · Halibrell, Labigat
Denmark · Labigat
Estonia · Halibrell, Ralik
Spain · Labigat, Ranolazina Alter
France · Ranolazine Micro Labs
United Kingdom (Northern Ireland) · Ranolazine, Ranolazine Accord
Greece · Labigat, Lakosun
Croatia · Halibrell, Lasokun
Ireland · Ranolazine Accord, Ranolazine Clonmel
Iceland · Ranexa
Italy · Labigat, Ranolazina Accord
Liechtenstein · Ranexa
Lithuania · Halibrell, Lasokun
Latvia · Halibrell, Lasokun
Netherlands · Lazela, Ranogelan
Norway · Ranexa
Portugal · Ranolazina Adamed, Ranolazina Bluepharma
Romania · Ranolazina Atb
Slovenia · Halibrell, Ranolazin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d5078a2e-ac5e-4b34-82f9-451d0cf5ddd4
GET /v1/drugs/d5078a2e-ac5e-4b34-82f9-451d0cf5ddd4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909991608194 ¦ Rp ¦ 168231\n30 tabl.\n05909991608200 ¦ Rp ¦ 168232\n60 tabl.\n05909991608217 ¦ Rp ¦ 168233\n100 tabl.",
  "substance": "Ranolazinum 500 mg",
  "common_name": "Ranolazinum",
  "pl_product_id": "100512100",
  "pozwolenie_nr": "29892",
  "auth_procedure": "DCP",
  "authorisation_validity": "2031-08-20"
}

API reference MCP server Plans

See everything about ranolazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console